Average Co-Inventor Count = 4.21
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bioaxone Biosciences, Inc. (12 from 12 patents)
12 patents:
1. 12384759 - Rho kinase inhibitor ba-1049 (r) and active metabolites thereof
2. 11814361 - Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
3. 11701366 - Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
4. 11324802 - C3 fusion protein and methods of making and using thereof
5. 11198680 - Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
6. 11098308 - Treatment of CNS injury with RNAi therapeutics
7. 10857157 - Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
8. 10537567 - Kinase inhibitors for treatment of disease
9. 10526313 - Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
10. 10149856 - Treatment of cerebral cavernous malformations and cerebral aneurysms with rho kinase inhibitors
11. 10106525 - Rho kinase inhibitor BA-1049 (R) and active metabolites thereof
12. 9687483 - Treatment of cerebral cavernous malformations and cerebral aneurysms with Rho kinase inhibitors